These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28689274)

  • 1. Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility.
    Ciccacci C; Latini A; Politi C; Mancinelli S; Marazzi MC; Novelli G; Palombi L; Borgiani P
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1253-1259. PubMed ID: 28689274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine.
    Ciccacci C; Politi C; Mancinelli S; Ciccacci F; Lucaroni F; Novelli G; Marazzi MC; Palombi L; Borgiani P
    J Antimicrob Chemother; 2018 Aug; 73(8):2137-2140. PubMed ID: 29762688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility.
    Ciccacci C; Rufini S; Mancinelli S; Buonomo E; Giardina E; Scarcella P; Marazzi MC; Novelli G; Palombi L; Borgiani P
    Int J Mol Sci; 2015 Mar; 16(3):5830-8. PubMed ID: 25775161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.
    Borgiani P; Di Fusco D; Erba F; Marazzi MC; Mancinelli S; Novelli G; Palombi L; Ciccacci C
    Eur J Clin Pharmacol; 2014 Mar; 70(3):275-8. PubMed ID: 24322967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study.
    Ciccacci C; Di Fusco D; Marazzi MC; Zimba I; Erba F; Novelli G; Palombi L; Borgiani P; Liotta G
    Eur J Clin Pharmacol; 2013 Nov; 69(11):1909-16. PubMed ID: 23774940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
    Singh HO; Lata S; Angadi M; Bapat S; Pawar J; Nema V; Ghate MV; Sahay S; Gangakhedkar RR
    Pharmacogenomics J; 2017 Jan; 17(1):53-60. PubMed ID: 26667829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.
    Carr DF; Chaponda M; Cornejo Castro EM; Jorgensen AL; Khoo S; Van Oosterhout JJ; Dandara C; Kampira E; Ssali F; Munderi P; Lalloo DG; Heyderman RS; Pirmohamed M
    J Antimicrob Chemother; 2014 Dec; 69(12):3329-34. PubMed ID: 25147095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Fagot JP; Mockenhaupt M; Bouwes-Bavinck JN; Naldi L; Viboud C; Roujeau JC;
    AIDS; 2001 Sep; 15(14):1843-8. PubMed ID: 11579247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
    Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
    Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007 - 2012.
    Dube N; Adewusi E; Summers R
    S Afr Med J; 2013 May; 103(5):322-5. PubMed ID: 23971123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
    Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
    Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.
    Carr DF; Bourgeois S; Chaponda M; Takeshita LY; Morris AP; Castro EM; Alfirevic A; Jones AR; Rigden DJ; Haldenby S; Khoo S; Lalloo DG; Heyderman RS; Dandara C; Kampira E; van Oosterhout JJ; Ssali F; Munderi P; Novelli G; Borgiani P; Nelson MR; Holden A; Deloukas P; Pirmohamed M
    J Antimicrob Chemother; 2017 Apr; 72(4):1152-1162. PubMed ID: 28062682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.
    Ueta M; Sawai H; Sotozono C; Hitomi Y; Kaniwa N; Kim MK; Seo KY; Yoon KC; Joo CK; Kannabiran C; Wakamatsu TH; Sangwan V; Rathi V; Basu S; Ozeki T; Mushiroda T; Sugiyama E; Maekawa K; Nakamura R; Aihara M; Matsunaga K; Sekine A; Gomes JÁ; Hamuro J; Saito Y; Kubo M; Kinoshita S; Tokunaga K
    J Allergy Clin Immunol; 2015 Jun; 135(6):1538-45.e17. PubMed ID: 25672763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.
    Nakatani K; Ueta M; Khor SS; Hitomi Y; Okudaira Y; Masuya A; Wada Y; Sotozono C; Kinoshita S; Inoko H; Tokunaga K
    Sci Rep; 2019 Nov; 9(1):16240. PubMed ID: 31700100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
    Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
    Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the association of Lamotrigine and Phenytoin-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis with HLA-B*1502 in Iranian population.
    Sabourirad S; Mortezaee R; Mojarad M; Eslahi A; Shahrokhi Y; Kiafar B; Jarahi L; Afkhami Ardakani S; Farrokhi S
    Exp Dermatol; 2021 Feb; 30(2):284-287. PubMed ID: 33217035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X; Liu W; Zhou W
    J Clin Pharm Ther; 2018 Jun; 43(3):408-413. PubMed ID: 29274302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
    Okamoto-Uchida Y; Nakamura R; Matsunaga K; Aihara M; Saito Y
    Pharmacogenet Genomics; 2018 Mar; 28(3):95-98. PubMed ID: 29239905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.